Description:

Sofvasc HCT (5/160/25)Tablets:

Sofvasc HCT (5/160/25) Tablets address hypertension and cardiac edoema. Nephrotic Syndrome treatment. Indicated for essential hypertension as substitute therapy in adults whose blood pressure is satisfactorily managed on amlodipine, valsartan, and hydrochlorothiazide (hct), given as three single-component formulations or as a dual-component and a single-component formulation. The fixed-combination medicine isn’t recommended for hypertension treatment.

The combination of Amlodipine, valsartan, and hydrochlorothiazide (Onato HCT) is used to treat high blood pressure (hypertension).

Manufacturer: Wilson Pharmaceuticals

Formulation:

Sofvasc HCT (5/160/25)) contains

1. Amlodipine (as Besylate) ph.eur …………….5mg
2. Valsartan usp ……………………………………….160 mg
3. Hychlorthiazide b.p………………………………25mg

Mechanism of Action:

The Drug Amlodipine belongs to the calcium channel antagonist class and valsartan is also an antagonist II class and hydrochlorothiazide belongs to the diuretic class. This combination makes this product very effective.

How to get:

Avail of this product by logging on to fareedpharma.com or by using the WhatsApp link.

Side Effects:

Lowers blood pressure in hypertensive individuals and treats heart disease-related edema. Nephrotic syndrome is another usage.

Contraindication:

Contraindicated in patients suffering from renal (kidney) decompensation and anuria. This drug is not safe for renal failure so consult your physician before using the medication.

Dosage:

Adults:

• Take one tablet daily after meals

Children:

• Not recommended in children

Availabilty:

1.  (5/160/12.5)
2.  (5/160/25)
3.  (10/160/12.5)
4.  (10/160/25)